Multus logo — Better media, by design

Multus

Better media, by design

Founded 2020 United Kingdom London, United Kingdom 27 employees Seed Total: $10.14M Agriculture, Biotechnology +2

General Information

Company Name Multus
Founded Year 2020
Location United Kingdom London, United Kingdom
Employees 27
Industries Agriculture, Biotechnology, Food and Beverage +1
Funding Stage Seed
Business Model B2B, SaaS, D2C
Revenue Model Service Fee, Subscription, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Multus. To contact Multus, visit multus.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Multus compare?

A PDF of Multus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Multus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Multus

Multus, founded in 2020, is a pioneering force in the realm of Agriculture, Biotechnology, and Food and Beverage industries, with its headquarters in the United Kingdom. Their slogan, "Better media, by design," encapsulates their innovative approach to cell culture media development.

By leveraging cutting-edge technologies such as high-throughput robotic automation and machine learning, Multus is poised to transform the landscape of biomanufacturing. Their mission is to significantly reduce the time to market and enhance supply chain stability for biomanufacturing companies globally.

The company's recent funding, a £2.15M grant from Innovate UK in January 2023, highlights investor confidence in their capabilities and market potential. With a robust, multi-disciplinary team, Multus stands at the forefront of creating resource-efficient solutions critical for the advancement of essential therapies, food, and materials in the global bioeconomy.

Business keywords: cell culture media, biomanufacturing, high-throughput robotic automation, cultivated meat, animal-free growth media, cellular agriculture, bioengineering, synthetic biology, foodtech, bioeconomy, cell therapies, genetic engineering

Services & Products

AI-Enabled MediOP™ Platform
Custom Media Development
Ready-Made Formulations
Rapid Prototyping
Global Scalable Production

Target Customers

Biomanufacturing Companies Pharmaceutical Industry Biologics Producers Cellular Agriculture Startups Advanced Therapy Research Labs

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant £380.00K 1
UK Research and Innovation
01 Jun 2025
Grant £7.90M 3
Big Idea Ventures, Mandi Ventures +1
01 Jan 2023
Seed £1.50M 4
SOSV, Martin Ventures +2
01 Jul 2021
Convertible Note Undisclosed 2
SOSV, indiebio
01 Apr 2021
Grant £110.00K 1
UK Research and Innovation
01 Jan 2021
Seed $250.00K 2
SOSV, indiebio
01 May 2020

Multus Alternatives & Competitors

View All Alternatives
Multus vs

Jimi Biotech develops delicious meat directly from animal cells, without slaughtering.

Angel
10 employees
Biotechnology, Food and Beverage
Multus vs
Omeat
Omeat United States

Meat made better in every way

Series A
20 employees
Biotechnology, Food and Beverage
Multus vs
Novel Farms, Inc.
Novel Farms, Inc. United States

Sustainably manufacturing animal cells to tunable specifications

Grant
2 employees
Biotechnology, Food and Beverage

FAQ About Multus

Better media, by design
Multus was founded in 2020.
Multus is headquartered in London, United Kingdom.
Multus operates in Agriculture, Biotechnology, Food and Beverage and AgriTech. Its work centres on cell culture media, biomanufacturing, high-throughput robotic automation and cultivated meat. Its customers include Biomanufacturing Companies, Pharmaceutical Industry and Biologics Producers.
Multus has a B2B, SaaS and D2C business model. Its revenue comes from Service Fee, Subscription and Product Sales.
Multus has approximately 27 employees.
Multus has completed 6 funding rounds, raising a total of $10.14M. The latest funding stage is Seed.
Multus offers: AI-Enabled MediOP™ Platform, Custom Media Development, Ready-Made Formulations, Rapid Prototyping, Global Scalable Production.
Top alternatives and competitors to Multus include Jimi Biotech, Omeat, Novel Farms, Inc., Nexture Bio, Nordic Virtual Pastures. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Multus and Jimi Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Multus, https://bouncewatch.com/company/multus-media, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes